Soligenix's Breakthrough: Safety Success in T-Cell Lymphoma Trial Sparks Investor Frenzy and Multi-Day Rally Prospects
Soligenix Forges Ahead: Celebrating Groundbreaking Milestones and Robust Financial Growth in Q2 2024
Soligenix Soars: Groundbreaking Progress and Robust Financials Propel Q2 2025 Success